Contrast agent gadobenate dimeglumine may be safe for patients with renal disease who require dialysis.
Use of contrast agent gadobenate dimeglumine among patients with renal disease who are undergoing dialysis appears to be safe, according to a study published in Radiology.
Researchers from Emory University in Atlanta, Georgia, sought to determine the incidence of nephrogenic systemic fibrosis (NSF) in patients who are undergoing peritoneal dialysis, hemodialysis, or nondialysis who received gadobenate dimeglumine.
A total of 172 women and 229 men (mean age of 50) participated in the study; 75.5% (303 patients) were dialysis-dependent, with a mean eGFR ± standard deviation of 17 mL/min per 1.73 m2 ± 5.6 (range, 6–41 mL/min per 1.73 m2; median, 16.3 mL/min per 1.73 m2). In the nondialysis group (98 patients), 94 had chronic renal failure and four had acute renal failure. The patients had an abnormal estimated glomerular filtration rate (eGFR), and underwent MR imaging and/or MR angiography with gabobenate dimeglumine in 2010.
The mean follow-up was 2.35 years, during which time no patient was diagnosed with NSF.[[{"type":"media","view_mode":"media_crop","fid":"42306","attributes":{"alt":"","class":"media-image media-image-right","id":"media_crop_6467222157478","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"4557","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 124px; width: 200px; border-width: 0px; border-style: solid; margin: 1px; float: right;","title":"©sfam photo/Shutterstock.com","typeof":"foaf:Image"}}]]
The researchers concluded that study subjects with renal failure who were undergoing peritoneal dialysis, hemodialysis, or nondialysis with renal failure did not develop NSF after administration of gadobenate dimeglumine. “Gadobenate dimeglumine may be safe in this population,” they wrote.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 3
August 6th 2025In the last of a three-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, share additional insights on practical considerations and potential challenges in integrating abbreviated breast MRI into clinical practice, and offer their thoughts on future research directions.
Large Medicare Study Shows Black Men Less Likely to Receive PET and MRI for Prostate Cancer Imaging
August 6th 2025An analysis of over 749,000 Medicare beneficiaries diagnosed with prostate cancer over a five-year period found that Black men were 13 percent less likely to receive PET imaging and 16 percent less likely to receive MRI in comparison to White men.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 3
August 6th 2025In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.